Raymond James & Associates Turning Point Therapeutics, Inc. Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$24.32 - $75.3 $254,581 - $788,240
-10,468 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$24.73 - $51.25 $39,518 - $81,897
1,598 Added 18.02%
10,468 $281,000
Q4 2021

Feb 08, 2022
SELL
$35.48 - $67.33 $40,021 - $75,948
-1,128 Reduced 11.28%
8,870 $423,000
Q3 2021

Nov 02, 2021
SELL
$61.0 - $81.99 $22,143 - $29,762
-363 Reduced 3.5%
9,998 $664,000
Q2 2021

Aug 11, 2021
SELL
$62.93 - $90.59 $5,663 - $8,153
-90 Reduced 0.86%
10,361 $808,000
Q1 2021

May 14, 2021
SELL
$88.19 - $140.01 $11,552 - $18,341
-131 Reduced 1.24%
10,451 $989,000
Q4 2020

Feb 12, 2021
SELL
$87.69 - $130.94 $42,441 - $63,374
-484 Reduced 4.37%
10,582 $1.29 Million
Q3 2020

Nov 04, 2020
SELL
$56.99 - $89.33 $15,159 - $23,761
-266 Reduced 2.35%
11,066 $967,000
Q2 2020

Jul 28, 2020
BUY
$39.94 - $70.39 $452,600 - $797,659
11,332 New
11,332 $732,000

About Turning Point Therapeutics, Inc.

TPTX Quotes by TradingView
  • Ticker TPTX
  • Exchange NASDAQ
  • Shares Outstandng 50,074,300
More about TPTX
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email